Definitive Healthcare Corp. (NASDAQ:DH) Receives $5.35 Consensus PT from Analysts

Shares of Definitive Healthcare Corp. (NASDAQ:DH) have received an average rating of “Hold” from the twelve ratings firms that are presently covering the company, Marketbeat Ratings reports. Two investment analysts have rated the stock with a sell rating, seven have given a hold rating and three have given a buy rating to the company. The average twelve-month price target among brokerages that have issued a report on the stock in the last year is $5.35.

A number of brokerages recently weighed in on DH. Needham & Company LLC restated a “hold” rating on shares of Definitive Healthcare in a research report on Thursday, January 16th. Stephens began coverage on Definitive Healthcare in a research report on Friday, December 20th. They set an “equal weight” rating and a $5.00 price objective on the stock. Barclays reduced their price objective on Definitive Healthcare from $4.00 to $3.00 and set an “underweight” rating on the stock in a research report on Monday, March 3rd. Finally, The Goldman Sachs Group reduced their price objective on Definitive Healthcare from $4.50 to $3.00 and set a “neutral” rating on the stock in a research report on Tuesday, March 4th.

Definitive Healthcare Stock Performance

Shares of DH opened at $2.59 on Friday. Definitive Healthcare has a 52-week low of $2.55 and a 52-week high of $8.35. The business’s fifty day moving average is $4.34 and its 200-day moving average is $4.37. The company has a debt-to-equity ratio of 0.33, a quick ratio of 2.49 and a current ratio of 2.49. The firm has a market cap of $292.44 million, a price-to-earnings ratio of -0.84, a PEG ratio of 4.06 and a beta of 1.51.

Definitive Healthcare (NASDAQ:DH) last issued its quarterly earnings results on Thursday, February 27th. The company reported $0.03 earnings per share (EPS) for the quarter, missing the consensus estimate of $0.07 by ($0.04). Definitive Healthcare had a negative net margin of 142.38% and a positive return on equity of 1.76%. The business had revenue of $62.29 million during the quarter, compared to the consensus estimate of $60.60 million. Equities analysts anticipate that Definitive Healthcare will post 0.16 EPS for the current fiscal year.

Institutional Inflows and Outflows

Hedge funds and other institutional investors have recently bought and sold shares of the stock. Nisa Investment Advisors LLC lifted its stake in shares of Definitive Healthcare by 3,652.7% in the 4th quarter. Nisa Investment Advisors LLC now owns 6,980 shares of the company’s stock valued at $29,000 after purchasing an additional 6,794 shares during the period. Bayesian Capital Management LP acquired a new position in shares of Definitive Healthcare in the 4th quarter valued at about $41,000. Point72 DIFC Ltd lifted its stake in shares of Definitive Healthcare by 759.9% in the 3rd quarter. Point72 DIFC Ltd now owns 9,296 shares of the company’s stock valued at $42,000 after purchasing an additional 8,215 shares during the period. Ieq Capital LLC acquired a new position in shares of Definitive Healthcare in the 4th quarter valued at about $51,000. Finally, KLP Kapitalforvaltning AS acquired a new position in shares of Definitive Healthcare in the 4th quarter valued at about $54,000. 98.67% of the stock is owned by institutional investors and hedge funds.

Definitive Healthcare Company Profile

Definitive Healthcare Corp., together with its subsidiaries, provides software as a service (SaaS) healthcare commercial intelligence platform in the United States and internationally. Its SaaS platform provides information on healthcare providers and their activities to help its customers from product development to go-to-market planning, and sales and marketing execution.